Skip to main content

Table 1 Characteristics of included studies (Part 1)

From: Role of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a systematic review and meta-analysis of randomized controlled trials

  

UDCA supplementation group (UDCA + phototherapy)

Control group (phototherapy only)

No

Author

Number of participants

Mean age (SD)

Female (n)

Weight (g)

TSB (mg/dL)

Therapy

Number of participants

Mean age (SD)

Female (n)

Weight (g)

TSB (mg/dL)

1

Akefi [25]

110

5.3 (2.9)

62

16.8 (2.4)

UDCA 10 mg/kg/d

110

4.9 (2.1)

52

15.7 (2.5)

2

El-Gendy [26]

50

4,9 (1.44)

20

16.5 (1.51)

UDCA 1*

50

4.86 (1.6)

24

16.4 (1.57)

3

Gharehbaghi [27]

80 (A = 40, B = 40)

A = 5.91 (2.49),

B = 5.1 (2.47)

A = 18, B = 16

A = 3175.41 (561.53), B = 2961.71 (440.03)

A = 19.88 (2.33), B = 19.33 (2.51)

A = UDCA 1*

B = UDCA 2*

40

5.91 (2.49)

18

3192.91 (431.02)

19.76 (2.64)

4

Hassan [28]

100

5.4 (1.4)

44

3.2 (0.4) (in kg)

16.3 (1.7)

UDCA 1*

100

5.3 (1.5)

49

3.1 (0.4) (in kg)

16.5 (2.9)

5

Honar [21]

40

3.7 (1)

21

2970 (292)

15.9 (1.7)

UDCA 1*

40

3.6 (1)

22

2985 (312)

16.3 (1.5)

6

Jafari [29]

64 (A = 32, B = 32)

A = 16.47 (1.65),

B = 16.22 (1.67)

A = UDCA 1*

B = UDCA 3*

32

16.64 (1.72)

7

Meena [30]

50

19

2.73 (0.23)

16.33 (1.58)

UDCA 1*

50

17

2.69 (0.41)

15.6 (2.78)

8

Shahramian [31]

100

47

UDCA 2*

100

48

  1. UDCA 1* UDCA 10 mg/kg/day divided every 12 h, UDCA 2* UDCA 15 mg/kg/day divided every 12 h, UDCA 3* UDCA 20 mg/kg/day divided every 12 h